| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Diagnosis and Treatment of Sacroiliac Joint Pain | 2026-05-01 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Rituximab (Rituxan), Rituximab Biosimilars, and Rituximab and Hyaluronidase Human (Rituxan Hycela) | 2026-05-01 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Octreotide acetate (Sandostatin, Sandostatin LAR) and Lanreotide (Somatuline Depot) | 2026-05-01 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Luspatercept (Reblozyl) | 2026-05-01 |
| BCBS Highmark Penn CPA/SEPA/WPA/NEPA | Programmed Death Receptor (PD-1)/ Programmed Death-Ligand (PD-L1) Blocking Antibodies | 2026-05-01 |
| BCBS Highmark Penn Medicare Advantage | Amivantamab and Hyaluronidase-lpuj (Rybrevant Faspro) | 2026-05-01 |
| BCBS Highmark Penn Medicare Advantage | Bevacizumab-tnjn (Avizi) | 2026-05-01 |
| BCBS Highmark Penn Medicare Advantage | Programmed Death Receptor (PD-1)/ Programmed Death-Ligand (PD-L1) Blocking Antibodies | 2026-05-01 |
| BCBS Highmark Penn Medicare Advantage | Zoledronic Acid (Reclast, Zometa) | 2026-05-01 |
| BCBS Highmark Penn Medicare Advantage | Octreotide acetate (Sandostatin, Sandostatin LAR) and Lanreotide (Somatuline Depot) | 2026-05-01 |